OBJECTIVE: To describe survival outcomes for pediatric patients supported with extracorporeal membrane oxygenation for severe myocarditis and identify risk factors for in-hospital mortality. DESIGN: Retrospective review of Extracorporeal Life Support Organization registry database. SETTING: Data reported to Extracorporeal Life Support Organization from 116 extracorporeal membrane oxygenation centers. PATIENTS: Patients < or = 18 yrs of age supported with extracorporeal membrane oxygenation for myocarditis during 1995 to 2006. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Of 19,348 reported pediatric extracorporeal membrane oxygenation uses from 1995 to 2006, 260 runs were for 255 patients with a diagnosis of myocarditis (1.3%). Survival to hospital discharge was 61%. Seven patients (3%) underwent heart transplantation and six patients survived to discharge. Of 100 patients not surviving to hospital discharge, extracorporeal membrane oxygenation support was withdrawn in 70 (70%) with multiple organ failure as the indication in 58 (83%) patients. In a multivariable model, female gender (adjusted odds ratio, 2.3, 95% confidence interval, 1.3-4.2), arrhythmia on extracorporeal membrane oxygenation (adjusted odds ratio, 2.7, 95% confidence interval, 1.5-5.1), and renal failure requiring dialysis (adjusted odds ratio, 5.1, 95% confidence interval, 2.3-11.4) were associated with increased odds of in-hospital mortality. CONCLUSION: Extracorporeal membrane oxygenation is a valuable tool to rescue children with severe cardiorespiratory compromise related to myocarditis. Female gender, arrhythmia on extracorporeal membrane oxygenation, and need for dialysis during extracorporeal membrane oxygenation were associated with increased mortality.
OBJECTIVE: To describe survival outcomes for pediatric patients supported with extracorporeal membrane oxygenation for severe myocarditis and identify risk factors for in-hospital mortality. DESIGN: Retrospective review of Extracorporeal Life Support Organization registry database. SETTING: Data reported to Extracorporeal Life Support Organization from 116 extracorporeal membrane oxygenation centers. PATIENTS: Patients < or = 18 yrs of age supported with extracorporeal membrane oxygenation for myocarditis during 1995 to 2006. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Of 19,348 reported pediatric extracorporeal membrane oxygenation uses from 1995 to 2006, 260 runs were for 255 patients with a diagnosis of myocarditis (1.3%). Survival to hospital discharge was 61%. Seven patients (3%) underwent heart transplantation and six patients survived to discharge. Of 100 patients not surviving to hospital discharge, extracorporeal membrane oxygenation support was withdrawn in 70 (70%) with multiple organ failure as the indication in 58 (83%) patients. In a multivariable model, female gender (adjusted odds ratio, 2.3, 95% confidence interval, 1.3-4.2), arrhythmia on extracorporeal membrane oxygenation (adjusted odds ratio, 2.7, 95% confidence interval, 1.5-5.1), and renal failure requiring dialysis (adjusted odds ratio, 5.1, 95% confidence interval, 2.3-11.4) were associated with increased odds of in-hospital mortality. CONCLUSION: Extracorporeal membrane oxygenation is a valuable tool to rescue children with severe cardiorespiratory compromise related to myocarditis. Female gender, arrhythmia on extracorporeal membrane oxygenation, and need for dialysis during extracorporeal membrane oxygenation were associated with increased mortality.
Authors: M D Black; J G Coles; W G Williams; I M Rebeyka; G A Trusler; D Bohn; C Gruenwald; R M Freedom Journal: Ann Thorac Surg Date: 1995-07 Impact factor: 4.330
Authors: Marilyn C Morris; Richard F Ittenbach; Rodolfo I Godinez; Joel D Portnoy; Sarah Tabbutt; Brian D Hanna; Timothy M Hoffman; J William Gaynor; James T Connelly; Mark A Helfaer; Thomas L Spray; Gil Wernovsky Journal: Crit Care Med Date: 2004-04 Impact factor: 7.598
Authors: Neil E Bowles; Jiyuan Ni; Debra L Kearney; Matthias Pauschinger; Heinz-Peter Schultheiss; Robert McCarthy; Joshua Hare; J Timothy Bricker; Karla R Bowles; Jeffrey A Towbin Journal: J Am Coll Cardiol Date: 2003-08-06 Impact factor: 24.094
Authors: F Schmidt; T Jack; M Sasse; T Kaussen; H Bertram; A Horke; K Seidemann; P Beerbaum; H Koeditz Journal: Pediatr Cardiol Date: 2015-06-07 Impact factor: 1.655
Authors: Matthew M Laughon; Daniel K Benjamin; Edmund V Capparelli; Gregory L Kearns; Katherine Berezny; Ian M Paul; Kelly Wade; Jeff Barrett; Phillip Brian Smith; Michael Cohen-Wolkowiez Journal: Expert Rev Clin Pharmacol Date: 2011-09 Impact factor: 5.045
Authors: Melania M Bembea; William Savage; John J Strouse; Jamie McElrath Schwartz; Ernest Graham; Carol B Thompson; Allen Everett Journal: Pediatr Crit Care Med Date: 2011-09 Impact factor: 3.624
Authors: Joseph R Casadonte; Mjaye L Mazwi; Katheryn E Gambetta; Hannah L Palac; Mary E McBride; Osama M Eltayeb; Michael C Monge; Carl L Backer; John M Costello Journal: Pediatr Cardiol Date: 2016-11-08 Impact factor: 1.655
Authors: Rajesh Punn; David M Axelrod; Sara Sherman-Levine; Stephen J Roth; Theresa A Tacy Journal: Pediatr Crit Care Med Date: 2014-11 Impact factor: 3.624
Authors: Geoffrey M Fleming; Rashmi Sahay; Michael Zappitelli; Eileen King; David J Askenazi; Brian C Bridges; Matthew L Paden; David T Selewski; David S Cooper Journal: Pediatr Crit Care Med Date: 2016-12 Impact factor: 3.624